Handelsbanken Fonder’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Sell |
10,900
-200
| -2% | -$57.5K | 0.01% | 519 |
|
|
2025
Q1 | $3.42M | Hold |
11,100
| – | – | 0.01% | 506 |
|
|
2024
Q4 | $3.92M | Sell |
11,100
-1,900
| -15% | -$670K | 0.02% | 480 |
|
|
2024
Q3 | $4.66M | Buy |
13,000
+2,200
| +20% | +$788K | 0.02% | 443 |
|
|
2024
Q2 | $3.44M | Sell |
10,800
-900
| -8% | -$287K | 0.02% | 467 |
|
|
2024
Q1 | $2.69M | Buy |
11,700
+3,100
| +36% | +$712K | 0.01% | 538 |
|
|
2023
Q4 | $1.89M | Buy |
8,600
+700
| +9% | +$154K | 0.01% | 571 |
|
|
2023
Q3 | $1.78M | Buy |
7,900
+600
| +8% | +$135K | 0.01% | 567 |
|
|
2023
Q2 | $1.61M | Hold |
7,300
| – | – | 0.01% | 589 |
|
|
2023
Q1 | $1.64M | Buy |
7,300
+1,400
| +24% | +$314K | 0.01% | 571 |
|
|
2022
Q4 | $1.64M | Hold |
5,900
| – | – | 0.01% | 544 |
|
|
2022
Q3 | $1.24M | Hold |
5,900
| – | – | 0.01% | 598 |
|
|
2022
Q2 | $1.39M | Sell |
5,900
-800
| -12% | -$188K | 0.01% | 599 |
|
|
2022
Q1 | $1.2M | Hold |
6,700
| – | – | 0.01% | 723 |
|
|
2021
Q4 | $1.45M | Sell |
6,700
-2,600
| -28% | -$562K | 0.01% | 727 |
|
|
2021
Q3 | $1.72M | Buy |
9,300
+1,800
| +24% | +$332K | 0.01% | 666 |
|
|
2021
Q2 | $1.35M | Sell |
7,500
-800
| -10% | -$144K | 0.01% | 772 |
|
|
2021
Q1 | $1.39M | Hold |
8,300
| – | – | 0.01% | 711 |
|
|
2020
Q4 | $1.26M | Buy |
8,300
+1,500
| +22% | +$228K | 0.01% | 731 |
|
|
2020
Q3 | $687K | Hold |
6,800
| – | – | 0.01% | 845 |
|
|
2020
Q2 | $823K | Buy |
+6,800
| New | +$823K | 0.01% | 761 |
|
|
2016
Q1 | – | Sell |
-7,005
| Closed | -$1.1M | – | 570 |
|
|
2015
Q4 | $1.1M | Buy |
+7,005
| New | +$1.1M | 0.02% | 475 |
|